subject: CHEBI:9939

object_name: Delayed Emergence from Anesthesia


subject: UNII:73B0K5S26A

subject_name: Belimumab

object_name: neuromyelitis optica

tested_intervention: yes


subject: DRUGBANK:DB14297

subject_name: Arnica montana

object_name: Impacted third molar tooth

tested_intervention: unsure


subject: DRUGBANK:DB16564

subject_name: Mucopolysaccharide polysulphate


subject: CHEMBL.COMPOUND:CHEMBL2109199

subject_name: MUCOPOLYSACCHARIDE POLYSULFATE


subject: CHEBI:3125

subject_name: Bisacodyl

object_name: Abdominal pain


subject: CHEBI:3125

object_name: Abdominal Pain, CTCAE


subject: CHEBI:3125

object_name: post operative nausea and vomiting


subject: UNII:J89QT81NBQ

object_name: Recurrent oral herpes


subject: UMLS:C4490519


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Vitreous Hemorrhage, CTCAE 5.0


subject: UNII:ZL1R02VT79

object_name: Vitreous Hemorrhage, CTCAE 3.0


subject: UNII:ZL1R02VT79

object_name: Vitreous hemorrhage


subject: CHEBI:8988

object_name: Liposarcoma recurrent


subject: CHEBI:80630

subject_name: Irinotecan


subject: UNII:C6RWP0N0L2

subject_name: Silmitasertib

object_name: Recurrent Rhabdomyosarcoma


subject: UNII:C6RWP0N0L2

object_name: Ewing's sarcoma recurrent


subject: UNII:C6RWP0N0L2

object_name: Neuroblastoma recurrent


subject: UNII:C6RWP0N0L2

object_name: Osteosarcoma recurrent


subject: UNII:C6RWP0N0L2


subject: CHEBI:232617


subject: CHEBI:232617


subject: CHEBI:232617


subject: CHEBI:232617


subject: CHEBI:232617


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Endotoxemia


subject: CHEBI:18357

subject_name: Norepinephrine


subject: UMLS:C0376659

subject_name: Cancer Vaccines

object_name: lung cancer


subject: UMLS:C0376659

object_name: lung neoplasm


subject: UMLS:C0376659

object_name: lung carcinoma


subject: CHEBI:10119

subject_name: Ziprasidone

object_name: social phobia


subject: UMLS:C4508358

subject_name: ergoferon

object_name: Viral enteritis


subject: CHEBI:36791

subject_name: Escitalopram

object_name: epilepsy


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:132922

object_name: Impacted third molar tooth


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:175901

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:175901

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:175901

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:175901

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:3A58010674

subject_name: Pegfilgrastim

object_name: Breast cancer stage II


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UNII:3A58010674


subject: UNII:3A58010674

object_name: Her2-receptor negative breast cancer


subject: UMLS:C5417839

subject_name: Allosteric ErbB Inhibitor BDTX-189

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417839

object_name: Adult Solid Neoplasm


subject: UMLS:C5417839

object_name: Solid Neoplasm


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Unresectable Undifferentiated Pleomorphic Sarcoma


subject: GTOPDB:12990

object_name: Locally Advanced Undifferentiated Pleomorphic Sarcoma


subject: GTOPDB:12990

object_name: Malignant fibrous histiocytoma metastatic


subject: GTOPDB:12990

object_name: Malignant fibrous histiocytoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: DRUGBANK:DB16594

subject_name: Goldenseal

object_name: Adverse Herb-Drug Interactions


subject: DRUGBANK:DB16594

object_name: type 2 diabetes mellitus


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C4053601


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:16865

subject_name: Aminobutyrates

object_name: epilepsy


subject: UMLS:C0016904

subject_name: gamma-aminobutyric acid


subject: CHEBI:8024

subject_name: Perindopril

object_name: dilated cardiomyopathy


subject: UNII:7CDW97HUEX

subject_name: Linzagolix

object_name: kidney failure


subject: UNII:LIX4M9AIVM

subject_name: N-acetylsulfanilyl chloride

object_name: graft versus host disease


subject: UniProtKB:Q9I9N6

subject_name: ASC_DANRE Apoptosis-associated speck-like protein containing a CARD (sprot)


subject: PR:000015781

subject_name: steryl-sulfatase


subject: PR:000013514

subject_name: apoptosis-associated speck-like protein containing a CARD


subject: CHEBI:66910

subject_name: Axitinib

object_name: Non-clear cell renal cell carcinoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4287951

subject_name: pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine

object_name: HER2 positive breast carcinoma


subject: UMLS:C4287951

object_name: male breast carcinoma


subject: UMLS:C4287951

object_name: Malignant neoplasm of female breast


subject: UMLS:C4287951

object_name: malignant neoplasm of breast stage I


subject: UMLS:C4287951

object_name: Carcinoma breast stage I


subject: UMLS:C4287951

object_name: Residual Tumor


subject: CHEBI:34945

object_name: Indication for modification of patient status


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: UMLS:C4086530

subject_name: JAK2 Inhibitor

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: UMLS:C4086530

object_name: vitiligo


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: nervous system injury


subject: CHEBI:38290

object_name: Out-of-Hospital Cardiac Arrest


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: CHEBI:75441

object_name: type 1 diabetes mellitus 1


subject: CHEBI:75441

object_name: type 1 diabetes mellitus


subject: UMLS:C0062549

subject_name: gastrin 17


subject: UMLS:C0062549


subject: MESH:D007166

subject_name: Immunosuppressive Agents


subject: MESH:D007166


subject: UNII:45X7OU8C4J

subject_name: DOMVANALIMAB

object_name: Locally Advanced Gastric Adenocarcinoma


subject: UMLS:C5206853

subject_name: Domvanalimab


subject: GTOPDB:9334

subject_name: tigatuzumab

object_name: Carcinoma breast stage IV


subject: GTOPDB:9334

object_name: Childhood Breast Carcinoma


subject: GTOPDB:9334

object_name: breast carcinoma


subject: GTOPDB:9334

object_name: breast cancer


subject: GTOPDB:9334

object_name: triple-negative breast carcinoma


subject: GTOPDB:9334

object_name: Triple-Negative Breast Cancer Finding


subject: GTOPDB:9334

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: GTOPDB:9334

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: GTOPDB:9334

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL1743080

subject_name: TIGATUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL1743080


subject: CHEMBL.COMPOUND:CHEMBL1743080


subject: CHEMBL.COMPOUND:CHEMBL1743080


subject: CHEMBL.COMPOUND:CHEMBL1743080


subject: CHEMBL.COMPOUND:CHEMBL1743080


subject: CHEMBL.COMPOUND:CHEMBL1743080


subject: CHEMBL.COMPOUND:CHEMBL1743080


subject: CHEMBL.COMPOUND:CHEMBL1743080


subject: UMLS:C1831890


subject: UMLS:C1831890


subject: UMLS:C1831890


subject: UMLS:C1831890


subject: UMLS:C1831890


subject: UMLS:C1831890


subject: UMLS:C1831890


subject: UMLS:C1831890


subject: UMLS:C1831890


subject: CHEMBL.COMPOUND:CHEMBL5314341

subject_name: GLUCAGON

object_name: familial hyperinsulinism


subject: CHEMBL.COMPOUND:CHEMBL5314341

object_name: congenital isolated hyperinsulinism


subject: CHEBI:5391

subject_name: Glucagon


subject: CHEBI:5391


subject: UNII:CZO834LXQM

object_name: atrial flutter


subject: UNII:CZO834LXQM

object_name: Atrial Flutter by ECG Finding


subject: UNII:CZO834LXQM

object_name: Atrial Flutter, CTCAE


subject: PUBCHEM.COMPOUND:15605092


subject: PUBCHEM.COMPOUND:15605092


subject: PUBCHEM.COMPOUND:15605092


subject: CHEBI:31401

subject_name: Cilostazol

object_name: carotid atherosclerosis


subject: CHEBI:18067

subject_name: Phylloquinone

object_name: Adverse Event Associated with Coagulation


subject: CHEBI:18067

object_name: Blood coagulation pathway observation


subject: UMLS:C3714737

subject_name: Phytonadione Drug Class


subject: UMLS:C3714737


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: Pregnant


subject: CHEBI:93109

subject_name: Semaxanib

object_name: skin melanoma


subject: CHEBI:91083

subject_name: Romiplostim


subject: CHEBI:91398

subject_name: Tivantinib

object_name: Unresectable Hepatocellular Carcinoma


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Prostate cancer recurrent


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:36704

subject_name: Imiquimod


subject: MESH:C477385

subject_name: montanide ISA 51


subject: CHEBI:33699

subject_name: messenger RNA


subject: UMLS:C5706394

subject_name: Personalized Liposomal Neoantigen-based Peptide Vaccine EVX-01

object_name: Unresectable Melanoma


subject: UMLS:C5706394

object_name: metastatic melanoma


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:3996

subject_name: Cyclobenzaprine

object_name: liver cirrhosis


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: glioblastoma


subject: CHEBI:91450

object_name: Childhood Glioblastoma


subject: CHEBI:91450

object_name: Adult Gliosarcoma


subject: CHEBI:91450

object_name: gliosarcoma


subject: CHEBI:91450

object_name: Childhood Gliosarcoma


subject: CHEBI:29954

subject_name: L-tryptophan residue

object_name: celiac disease


subject: CHEBI:29954

object_name: inborn disorder of tryptophan metabolism


subject: CHEBI:27897

subject_name: tryptophan


subject: CHEBI:27897


subject: UMLS:C0982054

subject_name: Candida antigen

object_name: human papilloma virus infection


subject: CHEBI:134726

subject_name: Istradefylline

object_name: Apathy


subject: CHEBI:134726

object_name: On examination - apathetic


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: AIDS


subject: CHEBI:7421

subject_name: NAC


subject: UMLS:C5204484

subject_name: HDAC8 Inhibitor NBM-BMX


subject: UMLS:C5556442

subject_name: Clifutinib Besylate

object_name: adult acute myeloid leukemia


subject: UMLS:C4078046

object_name: staphylococcus aureus infection


subject: UNII:M0Q7802G2B

subject_name: Benzodiazepines

object_name: anxiety disorder


subject: UMLS:C4048284

subject_name: Benzodiazepine


subject: UMLS:C3536850

subject_name: Benzodiazepine [EPC]


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Klatskin Tumor


subject: CHEBI:68647

subject_name: Regorafenib


subject: UNII:K4KAC9XCCO

object_name: rheumatoid arthritis


subject: CHEBI:93775

subject_name: Amethopterin

object_name: ulcerative colitis


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: type 1 diabetes mellitus


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: Childhood Solid Neoplasm


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:6741

subject_name: Meloxicam

object_name: Acute lumbago


subject: CHEBI:3996

subject_name: Cyclobenzaprine


subject: UNII:91D9GV0Z28

subject_name: Durapatite

object_name: Cellulite


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: Candidiasis of vagina


subject: CHEBI:47519

object_name: vulvovaginal candidiasis


subject: CHEBI:28918

subject_name: Epinephrine

object_name: ventricular tachycardia


subject: CHEBI:6904

subject_name: Metoprolol

object_name: cardiac arrest


subject: CHEBI:6904

object_name: Cardiac Arrest, CTCAE


subject: CHEBI:6904

object_name: ventricular fibrillation


subject: CHEBI:6904

object_name: Ventricular Fibrillation by ECG Finding


subject: CHEBI:6904

object_name: continuous electrocardiogram ventricular fibrillation


subject: CHEBI:6904

object_name: Ventricular Fibrillation, CTCAE 3.0


subject: CHEBI:6904

object_name: Ventricular Fibrillation, CTCAE 5.0


subject: CHEBI:6904


subject: CHEBI:6904

object_name: cardiac conduction defect


subject: CHEBI:8499

subject_name: Propranolol

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:8499

object_name: clear cell renal carcinoma


subject: CHEBI:8499

object_name: renal cell adenocarcinoma


subject: CHEBI:8499

object_name: renal cell carcinoma


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: cardiomyopathy


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: graft versus host disease


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:34945

object_name: colorectal carcinoma


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: CHEBI:81916

subject_name: Pancrelipase

object_name: pancreatitis


subject: CHEBI:81916

object_name: Pancreatitis, CTCAE 5.0


subject: CHEBI:81916

object_name: Pancreatitis, CTCAE 3.0


subject: UNII:FQ3DRG0N5K


subject: UNII:FQ3DRG0N5K


subject: UNII:FQ3DRG0N5K


subject: UMLS:C1302030

subject_name: amylase / lipase / protease


subject: UMLS:C1302030


subject: UMLS:C1302030


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: MIT family translocation renal cell carcinoma


subject: CHEBI:233362

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:5441

subject_name: Glyburide

object_name: Acute Stroke


subject: CHEBI:5441

object_name: Acute Stroke Related to COVID-19


subject: PUBCHEM.COMPOUND:53387035

subject_name: Pradigastat

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C4045958


subject: UNII:LY583605Y8

subject_name: Alethine

object_name: adult lymphoma


subject: UNII:LY583605Y8

object_name: lymphoma


subject: UNII:LY583605Y8

object_name: pediatric lymphoma


subject: UMLS:C5691182

object_name: bronchiectasis


subject: CHEBI:6741

subject_name: Meloxicam

object_name: Symptomatic irreversible pulpitis


subject: CHEMBL.COMPOUND:CHEMBL4297577

subject_name: BELAPECTIN

object_name: Hepatic impairment


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: Albuminuria


subject: UMLS:C1145201

object_name: Disorder of transplanted kidney


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:16335

subject_name: Adenosine

object_name: Chronic coronary syndrome


subject: CHEBI:16582

subject_name: oxaluric acid

object_name: rectal carcinoma


subject: CHEBI:16582

object_name: rectal cancer


subject: CHEBI:16582

object_name: Childhood Rectal Carcinoma


subject: CHEBI:34779

subject_name: glyoxal


subject: CHEBI:34779


subject: CHEBI:34779


subject: CHEBI:8378

subject_name: Prednisolone

object_name: hypospadias


subject: CHEBI:8378

object_name: Penile hypospadias


subject: CHEBI:73524

subject_name: Leu-Ala-Asp

object_name: plasma cell myeloma


subject: CHEBI:73524

object_name: mantle cell lymphoma


subject: CHEBI:73524

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:73524

object_name: non-Hodgkin lymphoma


subject: CHEBI:73524

object_name: Hodgkin Disease


subject: PR:000009648


subject: PR:000009648


subject: PR:000009648


subject: PR:000009648


subject: PR:000009648


subject: PR:000006506


subject: PR:000006506


subject: PR:000006506


subject: PR:000006506


subject: PR:000006506


subject: PR:000014814

subject_name: SH2 domain-containing protein 2A


subject: PR:000014814


subject: PR:000014814


subject: PR:000014814


subject: PR:000014814


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: Recurrent disease


subject: UNII:Q46947FE7K

object_name: Global Relapse in Viscera


subject: UNII:Q46947FE7K

object_name: Global Relapse in Lymph Nodes


subject: UNII:Q46947FE7K

object_name: Relapse Following Intervention for Kawasaki Disease


subject: UNII:Q46947FE7K

object_name: Global Relapse


subject: UNII:Q46947FE7K

object_name: Global Relapse in Skin


subject: UNII:Q46947FE7K

object_name: Global Relapse in Blood


subject: UNII:V5Y646AW8S


subject: UNII:V5Y646AW8S


subject: UNII:V5Y646AW8S


subject: UNII:V5Y646AW8S


subject: UNII:V5Y646AW8S


subject: UNII:V5Y646AW8S


subject: UNII:V5Y646AW8S


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:2618


subject: CHEBI:6538

subject_name: Loratadine


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:6538


subject: CHEBI:50730

subject_name: Montelukast

object_name: periodontitis, chronic, adult


subject: CHEBI:50730

object_name: chronic periodontitis


subject: PUBCHEM.COMPOUND:71853

subject_name: Chitosan

object_name: Failure of osseointegration of dental implant


subject: CHEBI:57704

subject_name: cationic chitosan


subject: CHEBI:16261

subject_name: chitosan


subject: UMLS:C0393031

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0393031

object_name: malignant pancreatic neoplasm


subject: CHEBI:16044

subject_name: L-methionine residue

object_name: DIABETIC BLOOD GLUCOSE MONITORING


subject: CHEBI:16811

subject_name: Racemethionine


subject: UMLS:C1318898

subject_name: 5-alpha Reductase Inhibitor [EPC]

object_name: gender incongruence


subject: UMLS:C1318898

object_name: Transsexualism


subject: UMLS:C2936788

subject_name: 5-alpha Reductase Inhibitors


subject: UMLS:C2936788


subject: PUBCHEM.COMPOUND:521267

subject_name: (R)-Carvotanacetone


subject: CHEBI:50742

subject_name: cyproterone


subject: PUBCHEM.COMPOUND:3787925

subject_name: LYNESTRENOL


subject: UMLS:C0443077

subject_name: Corticosteroid series

object_name: autoimmune uveitis


subject: CHEMBL.COMPOUND:CHEMBL4802185

subject_name: MAPLIRPACEPT

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4802185

object_name: pediatric lymphoma


subject: UMLS:C4725956

subject_name: SIRPa-IgG4 Fc


subject: UMLS:C4725956


subject: UMLS:C4725956


subject: MESH:C000709231

object_name: plasmacytoma


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Weight loss


subject: CHEBI:28939

object_name: Weight Loss, CTCAE


subject: CHEBI:28939

object_name: digestive system neoplasm


subject: CHEBI:28939

object_name: Neoplasm of the gastrointestinal tract


subject: CHEBI:28939

object_name: bronchogenic carcinoma


subject: CHEBI:28939

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:28939

object_name: non-Hodgkin lymphoma


subject: CHEBI:28939

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:28939

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:28939

object_name: Hodgkin Disease


subject: UMLS:C1831768

subject_name: Transdermal Estrogen

object_name: Turner syndrome


subject: UMLS:C1831768

object_name: primary ovarian failure


subject: UMLS:C1831768

object_name: premature menopause


subject: CHEBI:151315

subject_name: Heparin

object_name: Inflammation


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:145296

subject_name: monoacylglycerol 22:4


subject: CHEBI:145296

object_name: plasma cell myeloma


subject: CHEBI:145296


subject: CHEBI:145296


subject: CHEBI:145296


subject: CHEBI:145296


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: impotence


subject: PUBCHEM.COMPOUND:92043599

object_name: Erectile Dysfunction, CTCAE


subject: PUBCHEM.COMPOUND:92043599

object_name: Erectile dysfunction


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579

object_name: prostate carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Bardet-Biedl syndrome 2


subject: CHEBI:6801

object_name: Bardet-Biedl syndrome


subject: CHEBI:6801

object_name: blindness


subject: CHEBI:6801

object_name: Impaired Vision


subject: CHEBI:17026

subject_name: Progesterone

object_name: Premenopausal symptoms


subject: CHEBI:17026

object_name: Premenopausal


subject: CHEBI:17026

object_name: Females


subject: CHEBI:82975

subject_name: Naloxegol

object_name: esophageal disorder


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: chronic hepatitis C virus infection


subject: UMLS:C0597418

subject_name: Rotavirus Vaccines

object_name: meningococcal infection


subject: UMLS:C5397359

subject_name: Vaccine product containing only Rotavirus antigen (medicinal product)


subject: PUBCHEM.COMPOUND:90488848

object_name: relapsing-remitting multiple sclerosis


subject: GTOPDB:1331

subject_name: ACTH


subject: UMLS:C3539087

subject_name: ACTH and synthetic analog preparations


subject: CHEBI:3892

subject_name: Corticotropin


subject: UMLS:C3490678

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C3490678

object_name: Embolism, Tumor


subject: UMLS:C3490678

object_name: Neoplasm Metastasis


subject: UMLS:C3490678

object_name: Advanced cancer


subject: UMLS:C3490677

subject_name: Tanibirumab


subject: UMLS:C3490677


subject: UMLS:C3490677


subject: UMLS:C3490677


subject: UMLS:C3827032

subject_name: Catequentinib Hydrochloride

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:33313

subject_name: polonium atom

object_name: AIDS


subject: CHEBI:49828

subject_name: Praseodymium


subject: CHEBI:73645

subject_name: Pro-Arg


subject: CHEBI:8645

subject_name: purpurin


subject: CHEBI:26308

subject_name: propyl group


subject: PR:000016426

subject_name: voltage-dependent calcium channel gamma-like subunit


subject: UMLS:C0034833

subject_name: Receptors, Progesterone


subject: PR:000012621

subject_name: progesterone receptor


subject: UMLS:C2365506

subject_name: PR Otic


subject: CHEBI:74800

subject_name: Pro-Val


subject: CHEBI:27446

subject_name: Penicillin V


subject: UNII:8D7B37T28G

subject_name: SATRAPLATIN

object_name: brain neoplasm


subject: UNII:8D7B37T28G

object_name: Solid Neoplasm


subject: UNII:8D7B37T28G


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Melanoma recurrent


subject: CHEBI:231350

subject_name: Pacritinib

object_name: T-cell and NK-cell neoplasm


subject: UMLS:C4288268

subject_name: Ruxolitinib Phosphate Cream

object_name: atopic eczema


subject: CHEBI:67357

subject_name: Dolastatin 10

object_name: malignant soft tissue neoplasm


subject: CHEBI:67357

object_name: sarcoma


subject: CHEBI:67357

object_name: ovarian cancer


subject: CHEBI:67357

object_name: ovarian neoplasm


subject: CHEBI:67357

object_name: ovarian carcinoma


subject: UMLS:C0082338

subject_name: dolastatin 10


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UMLS:C0082338


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: human papilloma virus infection


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEMBL.COMPOUND:CHEMBL2109416

object_name: metastatic melanoma


subject: CHEMBL.COMPOUND:CHEMBL2109416

object_name: melanoma


subject: CHEMBL.COMPOUND:CHEMBL2109416

object_name: Advanced Melanoma


subject: UMLS:C2984205

subject_name: Anti-GD2 Monoclonal Antibody MORAb-028


subject: UMLS:C2984205


subject: UMLS:C1564625

subject_name: Gebauer's Ethyl Chloride

object_name: Safety Issues


subject: CHEBI:47554

subject_name: Ethyl chloride


subject: CHEBI:36796

subject_name: duloxetine

object_name: Chronic depression


subject: CHEBI:291342

subject_name: Desloratadine

object_name: Inflammatory Response


subject: CHEBI:291342

object_name: Exertional Heat Illness


subject: UMLS:C4329512

subject_name: UCPVax

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:63605

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:63605

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:63605

object_name: anaplastic large cell lymphoma


subject: CHEBI:63605

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:63605

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: CHEBI:63605

object_name: Recurrent Adult Burkitt Lymphoma


subject: CHEBI:63605

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Metastatic malignant neoplasm to bone


subject: UNII:KXG2PJ551I

object_name: metastatic malignant neoplasm in the lymph nodes


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:48923

subject_name: erythromycin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:48923

object_name: obesity


subject: CHEBI:48923

object_name: Obesity, CTCAE


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:42355


subject: CHEBI:42355


subject: CHEBI:32129

subject_name: diamminesilver(1+) fluoride

object_name: secondary dentine


subject: CHEBI:8346

subject_name: Potassium Iodide


subject: CHEBI:50663

subject_name: Zanamivir

object_name: type 2 diabetes mellitus


subject: CHEBI:15365

subject_name: Aspirin

object_name: psychosis


subject: CHEBI:15365

object_name: Nonorganic psychosis


subject: CHEBI:15365

object_name: Psychosis, CTCAE


subject: CHEBI:15365

object_name: Acute psychosis


subject: CHEBI:7915

subject_name: Pantoprazole


subject: CHEBI:7915


subject: CHEBI:7915


subject: CHEBI:7915

object_name: schizophrenia


subject: CHEBI:4055

subject_name: Cytisine

object_name: Nicotine Addiction


subject: CHEBI:17224

subject_name: Hymecromone

object_name: interstitial lung disease


subject: CHEBI:17224

object_name: interstitial lung disease 1


subject: CHEBI:17224

object_name: interstitial lung disease 2


subject: UMLS:C2930770

object_name: Complicated intra-abdominal infection


subject: GTOPDB:12989

subject_name: toripalimab

object_name: stage II melanoma


subject: GTOPDB:12989

object_name: Stage II Cutaneous Melanoma AJCC v6 and v7


subject: GTOPDB:12989

object_name: acral lentiginous melanoma


subject: GTOPDB:12989

object_name: Acral Melanoma


subject: GTOPDB:12989

object_name: skin melanoma


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C4329337


subject: UMLS:C5667004

subject_name: Antibody-drug Conjugate TORL-2-307-ADC

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5667004

object_name: Stomach cancer


subject: UMLS:C5667004

object_name: gastric cancer


subject: UMLS:C5667004

object_name: pancreatic neoplasm


subject: UMLS:C5667004

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5667004

object_name: malignant pancreatic neoplasm


subject: UMLS:C5667004


subject: CHEBI:127342

subject_name: Atomoxetine

object_name: cancer


subject: CHEBI:127342

object_name: neoplasm


subject: CHEBI:73611

subject_name: Met-Gly

object_name: post-traumatic stress disorder


subject: CHEBI:25107

subject_name: magnesium atom


subject: PR:000004501

subject_name: attractin


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: anal squamous cell carcinoma


subject: UMLS:C3896806


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Langerhans cell histiocytosis


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:71954

subject_name: Buparlisib

object_name: basal cell carcinoma


subject: CHEBI:71954

object_name: skin basal cell carcinoma


subject: CHEBI:71954

object_name: nevoid basal cell carcinoma syndrome


subject: CHEBI:71954

object_name: Recurrent Skin Carcinoma


subject: CHEBI:71954

object_name: skin neoplasm


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90863


subject: CHEBI:231683

subject_name: Anakinra

object_name: autosomal recessive familial Mediterranean fever


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: Hypertrophic cardiomyopathy without obstruction


subject: CHEBI:77733

subject_name: Verapamil


subject: UMLS:C5556343

subject_name: Anti-EGFRvIII/CD3/PD-L1/4-1BB Tetra-specific Antibody GNC-039

object_name: Childhood Solid Neoplasm


subject: UMLS:C5556343

object_name: Adult Solid Neoplasm


subject: UMLS:C5556343

object_name: Solid Neoplasm


subject: UMLS:C5556343

object_name: Recurrent Glioma


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Cognitive impairment


subject: PUBCHEM.COMPOUND:73151030

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:73151030

object_name: Alzheimer disease


subject: CHEBI:6931

subject_name: Midazolam

object_name: Immune Tolerance


subject: CHEBI:6931

object_name: Drug Tolerance


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: Influenza caused by Influenza A virus subtype H7N9


subject: UNII:2DJ8R0NT7K

subject_name: LEVOKETOCONAZOLE

object_name: Cushing syndrome


subject: UNII:2DJ8R0NT7K

object_name: adrenal gland hyperfunction


subject: UNII:2DJ8R0NT7K

object_name: hyperaldosteronism


subject: UNII:2DJ8R0NT7K

object_name: Cushing Disease


subject: CHEBI:47519

subject_name: Ketoconazole


subject: CHEBI:47519


subject: CHEBI:47519


subject: CHEBI:47519


subject: UMLS:C0772447

subject_name: Disodium citrate

object_name: propionic acidemia


subject: CHEBI:17061

subject_name: D-Glutamine


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:18050

subject_name: L-Glutamine


subject: UNII:URK9D85MYO

subject_name: ornithine alpha-ketoglutarate


subject: UNII:4FEN49K96W

subject_name: ornithine oxoglurate


subject: GTOPDB:12690

subject_name: odronextamab

object_name: diffuse large B-cell lymphoma


subject: UNII:8R5CM46UIO

subject_name: ODRONEXTAMAB


subject: UMLS:C3896743

subject_name: Odronextamab


subject: UNII:4ADT8JXB9S

object_name: bronchiectasis


subject: UNII:4ADT8JXB9S

object_name: respiratory system disorder


subject: UNII:4ADT8JXB9S

object_name: lung disorder


subject: UMLS:C4045791


subject: UMLS:C4045791


subject: UMLS:C4045791


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Refractory Merkel Cell Carcinoma


subject: CHEBI:231614

object_name: Refractory Skin Squamous Cell Carcinoma


subject: CHEBI:231614

object_name: vulvar squamous cell carcinoma


subject: CHEBI:231614

object_name: basosquamous carcinoma


subject: CHEBI:231614

object_name: Porocarcinoma


subject: CHEBI:231614

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: CHEBI:231614

object_name: apocrine adenocarcinoma


subject: CHEBI:231614

object_name: skin appendage carcinoma


subject: CHEBI:231614

object_name: Primary Cutaneous Mucinous Carcinoma


subject: CHEBI:231614

object_name: Trichilemmal carcinoma


subject: CHEBI:231614

object_name: sweat gland carcinoma


subject: CHEBI:231614

object_name: hidradenocarcinoma


subject: CHEBI:231614

object_name: ductal eccrine adenocarcinoma


subject: CHEBI:231614

object_name: ALK-negative anaplastic large cell lymphoma


subject: CHEBI:231614

object_name: Extraocular Sebaceous Carcinoma


subject: CHEBI:231614

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:231614

object_name: Malignant cylindroma of skin


subject: CHEBI:231614

object_name: malignant spiradenoma


subject: CHEBI:231614

object_name: malignant syringoma


subject: CHEBI:231614

object_name: Squamoid eccrine ductal carcinoma


subject: CHEBI:231614

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: CHEBI:231614

object_name: cutaneous adenocystic carcinoma


subject: CHEBI:231614

object_name: gastric papillary adenocarcinoma


subject: CHEBI:231614

object_name: papillary adenocarcinoma


subject: CHEBI:231614

object_name: digital papillary eccrine carcinoma


subject: CHEBI:231614

object_name: papillary eccrine carcinoma


subject: CHEBI:231614

object_name: Endocrine mucin-producing sweat gland carcinoma


subject: CHEBI:231614

object_name: sweat gland cancer


subject: CHEBI:231614

object_name: keratoacanthoma


subject: CHEBI:231614

object_name: Sezary syndrome


subject: UMLS:C2346820

object_name: Refractory Merkel Cell Carcinoma


subject: UMLS:C2346820

object_name: Refractory Skin Squamous Cell Carcinoma


subject: UMLS:C2346820

object_name: vulvar squamous cell carcinoma


subject: UMLS:C2346820

object_name: basosquamous carcinoma


subject: UMLS:C2346820

object_name: Porocarcinoma


subject: UMLS:C2346820

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: UMLS:C2346820

object_name: apocrine adenocarcinoma


subject: UMLS:C2346820

object_name: skin appendage carcinoma


subject: UMLS:C2346820

object_name: Primary Cutaneous Mucinous Carcinoma


subject: UMLS:C2346820

object_name: Trichilemmal carcinoma


subject: UMLS:C2346820

object_name: sweat gland carcinoma


subject: UMLS:C2346820

object_name: hidradenocarcinoma


subject: UMLS:C2346820

object_name: ductal eccrine adenocarcinoma


subject: UMLS:C2346820

object_name: ALK-negative anaplastic large cell lymphoma


subject: UMLS:C2346820

object_name: Extraocular Sebaceous Carcinoma


subject: UMLS:C2346820

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UMLS:C2346820

object_name: Malignant cylindroma of skin


subject: UMLS:C2346820

object_name: malignant spiradenoma


subject: UMLS:C2346820

object_name: malignant syringoma


subject: UMLS:C2346820

object_name: Squamoid eccrine ductal carcinoma


subject: UMLS:C2346820

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UMLS:C2346820

object_name: cutaneous adenocystic carcinoma


subject: UMLS:C2346820

object_name: gastric papillary adenocarcinoma


subject: UMLS:C2346820

object_name: papillary adenocarcinoma


subject: UMLS:C2346820

object_name: digital papillary eccrine carcinoma


subject: UMLS:C2346820

object_name: papillary eccrine carcinoma


subject: UMLS:C2346820

object_name: Endocrine mucin-producing sweat gland carcinoma


subject: UMLS:C2346820

object_name: sweat gland cancer


subject: UMLS:C2346820

object_name: keratoacanthoma


subject: UMLS:C2346820

object_name: Sezary syndrome


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: Refractory Merkel Cell Carcinoma


subject: MESH:C000629782

object_name: skin squamous cell carcinoma


subject: MESH:C000629782

object_name: Refractory Skin Squamous Cell Carcinoma


subject: MESH:C000629782

object_name: vulvar squamous cell carcinoma


subject: MESH:C000629782

object_name: basosquamous carcinoma


subject: MESH:C000629782

object_name: skin basal cell carcinoma


subject: MESH:C000629782

object_name: Porocarcinoma


subject: MESH:C000629782

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: MESH:C000629782

object_name: apocrine adenocarcinoma


subject: MESH:C000629782

object_name: skin appendage carcinoma


subject: MESH:C000629782

object_name: Primary Cutaneous Mucinous Carcinoma


subject: MESH:C000629782

object_name: T-cell lymphoma refractory


subject: MESH:C000629782

object_name: NK-Cell Lymphoma, Unclassifiable


subject: MESH:C000629782

object_name: Trichilemmal carcinoma


subject: MESH:C000629782

object_name: Anaplastic large cell lymphoma T- and null-cell types refractory


subject: MESH:C000629782

object_name: sweat gland carcinoma


subject: MESH:C000629782

object_name: hidradenocarcinoma


subject: MESH:C000629782

object_name: ductal eccrine adenocarcinoma


subject: MESH:C000629782

object_name: ALK-negative anaplastic large cell lymphoma


subject: MESH:C000629782

object_name: ALK-positive anaplastic large cell lymphoma


subject: MESH:C000629782

object_name: Extraocular Sebaceous Carcinoma


subject: MESH:C000629782

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: MESH:C000629782

object_name: Malignant cylindroma of skin


subject: MESH:C000629782

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: MESH:C000629782

object_name: malignant spiradenoma


subject: MESH:C000629782

object_name: Mycosis fungoides refractory


subject: MESH:C000629782

object_name: malignant syringoma


subject: MESH:C000629782

object_name: Squamoid eccrine ductal carcinoma


subject: MESH:C000629782

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: MESH:C000629782

object_name: cutaneous adenocystic carcinoma


subject: MESH:C000629782

object_name: signet ring cell carcinoma


subject: MESH:C000629782

object_name: gastric papillary adenocarcinoma


subject: MESH:C000629782

object_name: papillary adenocarcinoma


subject: MESH:C000629782

object_name: T-cell lymphoma recurrent


subject: MESH:C000629782

object_name: digital papillary eccrine carcinoma


subject: MESH:C000629782

object_name: papillary eccrine carcinoma


subject: MESH:C000629782

object_name: Endocrine mucin-producing sweat gland carcinoma


subject: MESH:C000629782

object_name: sweat gland cancer


subject: MESH:C000629782

object_name: keratoacanthoma


subject: MESH:C000629782

object_name: extramammary Paget disease


subject: MESH:C000629782

object_name: Sezary syndrome


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec

object_name: Refractory Merkel Cell Carcinoma


subject: UNII:07730V90L6

object_name: skin squamous cell carcinoma


subject: UNII:07730V90L6

object_name: Refractory Skin Squamous Cell Carcinoma


subject: UNII:07730V90L6

object_name: vulvar squamous cell carcinoma


subject: UNII:07730V90L6

object_name: basosquamous carcinoma


subject: UNII:07730V90L6

object_name: skin basal cell carcinoma


subject: UNII:07730V90L6

object_name: Porocarcinoma


subject: UNII:07730V90L6

object_name: Squamous Cell Carcinoma of Unknown Primary


subject: UNII:07730V90L6

object_name: apocrine adenocarcinoma


subject: UNII:07730V90L6

object_name: skin appendage carcinoma


subject: UNII:07730V90L6

object_name: Primary Cutaneous Mucinous Carcinoma


subject: UNII:07730V90L6

object_name: T-cell lymphoma refractory


subject: UNII:07730V90L6

object_name: NK-Cell Lymphoma, Unclassifiable


subject: UNII:07730V90L6

object_name: Trichilemmal carcinoma


subject: UNII:07730V90L6

object_name: Anaplastic large cell lymphoma T- and null-cell types refractory


subject: UNII:07730V90L6

object_name: sweat gland carcinoma


subject: UNII:07730V90L6

object_name: hidradenocarcinoma


subject: UNII:07730V90L6

object_name: ductal eccrine adenocarcinoma


subject: UNII:07730V90L6

object_name: ALK-negative anaplastic large cell lymphoma


subject: UNII:07730V90L6

object_name: ALK-positive anaplastic large cell lymphoma


subject: UNII:07730V90L6

object_name: Extraocular Sebaceous Carcinoma


subject: UNII:07730V90L6

object_name: Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UNII:07730V90L6

object_name: Malignant cylindroma of skin


subject: UNII:07730V90L6

object_name: Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma


subject: UNII:07730V90L6

object_name: malignant spiradenoma


subject: UNII:07730V90L6

object_name: Mycosis fungoides refractory


subject: UNII:07730V90L6

object_name: malignant syringoma


subject: UNII:07730V90L6

object_name: Squamoid eccrine ductal carcinoma


subject: UNII:07730V90L6

object_name: Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma


subject: UNII:07730V90L6

object_name: cutaneous adenocystic carcinoma


subject: UNII:07730V90L6

object_name: signet ring cell carcinoma


subject: UNII:07730V90L6

object_name: gastric papillary adenocarcinoma


subject: UNII:07730V90L6

object_name: papillary adenocarcinoma


subject: UNII:07730V90L6

object_name: T-cell lymphoma recurrent


subject: UNII:07730V90L6

object_name: digital papillary eccrine carcinoma


subject: UNII:07730V90L6

object_name: papillary eccrine carcinoma


subject: UNII:07730V90L6

object_name: Endocrine mucin-producing sweat gland carcinoma


subject: UNII:07730V90L6

object_name: sweat gland cancer


subject: UNII:07730V90L6

object_name: keratoacanthoma


subject: UNII:07730V90L6

object_name: extramammary Paget disease


subject: UNII:07730V90L6

object_name: Sezary syndrome


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Pseudogout


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Radiculopathy, Cervical


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog


subject: CHEBI:9667

subject_name: Triamcinolone


subject: CHEBI:9570

subject_name: Thiotepa

object_name: Crohn disease


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: ureter transitional cell carcinoma


subject: UNII:28X28X9OKV

object_name: urethra transitional cell carcinoma


subject: UNII:28X28X9OKV

object_name: renal pelvis urothelial carcinoma


subject: UNII:28X28X9OKV

object_name: Bladder transitional cell carcinoma stage II


subject: UNII:28X28X9OKV

object_name: Bladder transitional cell carcinoma stage III


subject: UNII:28X28X9OKV

object_name: kidney pelvis sarcomatoid transitional cell carcinoma


subject: UNII:28X28X9OKV

object_name: Stage II Urethral Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IV Urethral Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage III Urethral Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IV Ureter Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage II Ureter Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage III Ureter Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage II Renal Pelvis Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IV Renal Pelvis Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage III Renal Pelvis Cancer AJCC v7


subject: UNII:28X28X9OKV

object_name: hydronephrosis


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX

object_name: infiltrating bladder urothelial carcinoma sarcomatoid variant


subject: UNII:QEN1X95CIX

object_name: plasmacytoid variant infiltrating bladder urothelial carcinoma


subject: UNII:QEN1X95CIX

object_name: micropapillary variant infiltrating bladder urothelial carcinoma


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073

object_name: ureter transitional cell carcinoma


subject: UMLS:C1948073

object_name: urethra transitional cell carcinoma


subject: UMLS:C1948073

object_name: renal pelvis urothelial carcinoma


subject: UMLS:C1948073

object_name: Bladder transitional cell carcinoma stage II


subject: UMLS:C1948073

object_name: Bladder transitional cell carcinoma stage III


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073

object_name: kidney pelvis sarcomatoid transitional cell carcinoma


subject: UMLS:C1948073

object_name: Stage II Urethral Cancer AJCC v7


subject: UMLS:C1948073

object_name: Stage IV Urethral Cancer AJCC v7


subject: UMLS:C1948073

object_name: Stage III Urethral Cancer AJCC v7


subject: UMLS:C1948073

object_name: Stage IV Ureter Cancer AJCC v7


subject: UMLS:C1948073

object_name: Stage II Ureter Cancer AJCC v7


subject: UMLS:C1948073

object_name: Stage III Ureter Cancer AJCC v7


subject: UMLS:C1948073

object_name: Stage II Renal Pelvis Cancer AJCC v7


subject: UMLS:C1948073

object_name: Stage IV Renal Pelvis Cancer AJCC v7


subject: UMLS:C1948073

object_name: Stage III Renal Pelvis Cancer AJCC v7


subject: UMLS:C1948073

object_name: hydronephrosis


subject: UMLS:C5854611

subject_name: SRC/YES1 Kinase Inhibitor NXP900

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5854611

object_name: renal carcinoma


subject: UMLS:C5854611

object_name: kidney cancer


subject: UMLS:C5854611

object_name: non-small cell squamous lung carcinoma


subject: UMLS:C5854611

object_name: non-small cell lung carcinoma


subject: UMLS:C5854611

object_name: non-small cell lung adenocarcinoma


subject: UMLS:C5854611

object_name: lung adenocarcinoma


subject: UMLS:C5854611

object_name: Mesothelioma


subject: UMLS:C5854611

object_name: mesothelial neoplasm


subject: UMLS:C5854611

object_name: malignant mesothelioma


subject: CHEBI:4735

subject_name: Edetic acid

object_name: type 2 diabetes mellitus


subject: CHEBI:4735

object_name: Diabetes


subject: CHEBI:4735

object_name: diabetes mellitus


subject: UMLS:C0038889

subject_name: Endogenous Surfactants

object_name: Primary Graft Dysfunction


subject: CHEBI:35195

subject_name: surfactant


subject: UMLS:C2825078

subject_name: Surfactant [EPC]


subject: UNII:Q4K217VGA9

subject_name: Calfactant


subject: UMLS:C4289970

subject_name: Anti-PD1 Monoclonal Antibody


subject: UMLS:C4289970

object_name: esophageal adenocarcinoma


subject: UMLS:C4289970


subject: UMLS:C4289970

object_name: cervical adenocarcinoma


subject: UMLS:C4289970

object_name: adenocarcinoma


subject: UMLS:C4289970

object_name: bile duct adenocarcinoma


subject: UMLS:C4289970

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C4289970

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C4289970

object_name: Embolism, Tumor


subject: UMLS:C4289970

object_name: Neoplasm Metastasis


subject: UMLS:C4289970

object_name: Adenocarcinoma, metastatic


subject: UMLS:C4289970

object_name: Oligometastatic malignant neoplasm


subject: UMLS:C4289970

object_name: gastric neoplasm


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: CHEBI:135919

subject_name: Nesiritide

object_name: hereditary endocrine growth disease


subject: CHEBI:135919

object_name: Wasting


subject: CHEBI:135919

object_name: Cachexia


subject: CHEBI:135919

object_name: anemia


subject: CHEBI:135919

object_name: Anemia, CTCAE


subject: CHEBI:16348

subject_name: Bovinocidin


subject: CHEBI:16348


subject: CHEBI:16348


subject: CHEBI:16348


subject: CHEBI:16348


subject: CHEBI:80234

subject_name: Brain natriuretic peptide


subject: CHEBI:80234


subject: CHEBI:80234


subject: CHEBI:80234


subject: CHEBI:80234


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Unresectable Liver Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Distal Bile Duct Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Metastatic Distal Cholangiocarcinoma


subject: UNII:52CMI0WC3Y


subject: UNII:52CMI0WC3Y

object_name: Recurrent Distal Cholangiocarcinoma


subject: UNII:52CMI0WC3Y

object_name: Metastatic Gallbladder Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Recurrent Cancer of Gallbladder


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: UNII:0125DUV5XC

subject_name: varlilumab


subject: UNII:0125DUV5XC


subject: UNII:0125DUV5XC


subject: UNII:0125DUV5XC

object_name: Stage IV Intrahepatic Cholangiocarcinoma AJCC v8


subject: UNII:0125DUV5XC


subject: UNII:0125DUV5XC


subject: UNII:0125DUV5XC


subject: UNII:0125DUV5XC


subject: UNII:0125DUV5XC


subject: UMLS:C3274549


subject: UMLS:C3274549


subject: UMLS:C3274549


subject: UMLS:C3274549


subject: UMLS:C3274549


subject: UMLS:C3274549


subject: UMLS:C3274549


subject: UMLS:C3274549


subject: UMLS:C3274549


subject: CHEBI:15859

subject_name: N-Carbamoylaspartic acid

object_name: multiple endocrine neoplasia


subject: CHEBI:15859

object_name: inherited lipid metabolism disorder


subject: UMLS:C3896904

subject_name: Fluorine F 18 L-glutamate Derivative BAY94-9392

object_name: pulmonary coin lesion


subject: UMLS:C3896904

object_name: lung carcinoma


subject: UNII:IJ34D6YPAO

subject_name: Polmacoxib

object_name: osteoarthritis


subject: UNII:72YOI2Q5AK

object_name: candidemia


subject: UMLS:C1144139

subject_name: lactoferrin (1-11), human


subject: UNII:86EEZ49YVB

subject_name: FOSTAMATINIB DISODIUM

object_name: EXCESS LMW-DNA


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib


subject: PUBCHEM.COMPOUND:172973390

subject_name: Ceftolozane-tazobactam

object_name: Bacteremia caused by Gram-negative bacteria


subject: UMLS:C3656593

subject_name: ceftolozane / tazobactam


subject: CHEBI:164200

subject_name: Triclosan

object_name: generalized aggressive periodontitis


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Postprandial hyperglycemia


subject: CHEBI:177425

subject_name: Patidegib

object_name: neoplasm


subject: UMLS:C0768182

subject_name: Bexxar

object_name: B-cell non-Hodgkin lymphoma


subject: UMLS:C0768182

object_name: B-cell neoplasm


subject: UNII:1LI341K7NQ

subject_name: CANFOSFAMIDE HYDROCHLORIDE

object_name: fallopian tube carcinoma


subject: UNII:1LI341K7NQ

object_name: fallopian tube cancer


subject: UNII:1LI341K7NQ

object_name: ovarian cancer


subject: UNII:1LI341K7NQ

object_name: ovarian neoplasm


subject: UNII:1LI341K7NQ

object_name: ovarian carcinoma


subject: UNII:1LI341K7NQ

object_name: peritoneum cancer


subject: CHEBI:135883

subject_name: Canfosfamide


subject: CHEBI:135883


subject: CHEBI:135883


subject: CHEBI:135883


subject: UMLS:C1258106

subject_name: TLK 286


subject: UMLS:C1258106


subject: UMLS:C1258106


subject: UMLS:C1258106


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Rash and Dermatitis Associated with Radiation Excluding Chemoradiation, CTCAE


subject: GTOPDB:9592

object_name: radiation exposure measurement


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:6754

subject_name: Meperidine

object_name: sciatica


subject: CHEBI:10093

subject_name: Yohimbine

object_name: social phobia


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: Small cell lung cancer extensive stage


subject: PR:000017019

object_name: trabecular adenocarcinoma


subject: PR:000017019

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UMLS:C3896806


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: PUBCHEM.COMPOUND:76322320

subject_name: COLISTIN

object_name: Pseudomonas aeruginosa infection


subject: CHEBI:37943

subject_name: colistin


subject: UMLS:C5447281

subject_name: Fluorine F 18 W372

object_name: Alzheimer disease


subject: CHEBI:114785

subject_name: Erlotinib

object_name: cervical adenocarcinoma


subject: CHEBI:114785

object_name: adenocarcinoma


subject: CHEBI:114785

object_name: bile duct adenocarcinoma


subject: UMLS:C0001645

subject_name: Adrenergic beta-Antagonists

object_name: Long Qt Syndrome 1-2


subject: UMLS:C0001645

object_name: cardiac conduction defect


subject: CHEBI:9241

subject_name: Spironolactone


subject: CHEBI:9241


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Vasculogenic erectile dysfunction


subject: UMLS:C1518386

subject_name: Non-Steroidal Aromatase Inhibitor

object_name: Neoplasm Metastasis


subject: UMLS:C1518386

object_name: breast neoplasm


subject: UMLS:C0677807

subject_name: Aminocamptothecin Colloidal Dispersion

object_name: ovarian cancer


subject: UMLS:C0677807

object_name: ovarian neoplasm


subject: UMLS:C0677807

object_name: ovarian carcinoma


subject: UMLS:C0677807

object_name: peritoneum cancer


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: progressive supranuclear palsy


subject: CHEBI:17460

subject_name: Thioctamide


subject: CHEBI:16494

subject_name: thioctic acid


subject: MESH:D013607

subject_name: Tablets

object_name: hepatitis B


subject: UNII:Q830PW7520

subject_name: CODEINE

object_name: Upper Respiratory Infections


subject: PUBCHEM.COMPOUND:2828


subject: CHEBI:57871


subject: CHEBI:16714

subject_name: Codeine


subject: CHEBI:93837

subject_name: Dropropizine


subject: CHEBI:82722

subject_name: Levodropropizine


subject: UNII:2O43FXG9IG

object_name: Age-associated memory impairment


subject: CHEBI:135654

subject_name: Imidapril

object_name: essential hypertension


subject: UMLS:C0247947

subject_name: exendin (9-39)

object_name: Appetite and general nutritional disorders


subject: CHEBI:32139

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C0717678

subject_name: dexamethasone / lidocaine

object_name: Low back pain


subject: UMLS:C0717678

object_name: intervertebral disk degenerative disorder


subject: UMLS:C0717678

object_name: lumbar disk degenerative disorder


subject: MESH:C000613428

subject_name: Afluria

object_name: influenza


subject: CHEBI:74947

subject_name: Thalidomide

object_name: Drug Resistant Epilepsy


subject: UMLS:C3642745

subject_name: ketamine topical

object_name: Neck Carcinoma


subject: UMLS:C3642745

object_name: head and neck neoplasm


subject: CHEBI:23359

subject_name: colchicine

object_name: Multi vessel coronary artery disease


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: mild neurocognitive disorder


subject: CHEBI:8228

object_name: mild cognitive impairment


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Non-small cell lung cancer stage III


subject: UNII:M89N0Q7EQR

object_name: Non-small cell lung cancer stage IIIA


subject: UNII:M89N0Q7EQR

object_name: Non-small cell lung cancer stage IIIB


subject: UNII:M89N0Q7EQR

object_name: Non-small cell lung cancer recurrent


subject: UNII:M89N0Q7EQR

object_name: Stage III Pleural Malignant Mesothelioma AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Pleural mesothelioma malignant advanced


subject: UNII:M89N0Q7EQR

object_name: Stage IV Pleural Malignant Mesothelioma AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Pleural mesothelioma malignant recurrent


subject: UNII:M89N0Q7EQR

object_name: WT1 Positive


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:74086836

subject_name: Sodium pertechnetate

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:74086836

object_name: coronary atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL2110571

subject_name: SODIUM PERTECHNETATE


subject: CHEMBL.COMPOUND:CHEMBL2110571


subject: CHEBI:33353

subject_name: technetium atom


subject: CHEBI:33353


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UMLS:C1832035


subject: UMLS:C1328236

subject_name: BRENTUXIMAB


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Adult Anaplastic Large Cell Lymphoma


subject: CHEBI:17650

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:17650

object_name: anaplastic large cell lymphoma


subject: CHEBI:17650


subject: CHEMBL.COMPOUND:CHEMBL2108893

subject_name: ALFIMEPRASE

object_name: Acute Ischemic Stroke


subject: CHEMBL.COMPOUND:CHEMBL2108893

object_name: Ischemic stroke


subject: UMLS:C1097921

subject_name: alfimeprase


subject: UMLS:C1097921


subject: UNII:M96ARL6373

subject_name: Flutriciclamide F-18

object_name: amyotrophic lateral sclerosis


subject: MESH:C000708863


subject: UMLS:C3491773


subject: UMLS:C5139697


subject: CHEBI:151315

subject_name: Heparin

object_name: nephrotic syndrome


subject: CHEBI:151315

object_name: Nephrotic Syndrome, CTCAE


subject: GTOPDB:6803

subject_name: dalteparin


subject: GTOPDB:6803


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UNII:PUE0TO3XDR


subject: DRUGBANK:DB21752

object_name: Childhood Breast Carcinoma


subject: DRUGBANK:DB21752

object_name: breast carcinoma


subject: DRUGBANK:DB21752

object_name: breast cancer


subject: UMLS:C5706323


subject: UMLS:C5706323


subject: UMLS:C5706323


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Advanced breast cancer


subject: CHEBI:74705

subject_name: Met-Leu

object_name: anesthesia; functional


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:2171

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:17489

subject_name: Cyclic AMP


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: cardiovascular disorder


subject: CHEBI:5118

object_name: heart disorder


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: adult lymphoma


subject: UNII:6GNT3Y5LMF

object_name: lymphoma


subject: UNII:6GNT3Y5LMF

object_name: pediatric lymphoma


subject: UNII:6GNT3Y5LMF

object_name: unspecified adult solid tumor, protocol specific


subject: UNII:6GNT3Y5LMF

object_name: extragonadal germ cell tumor


subject: UNII:6GNT3Y5LMF

object_name: testicular germ cell tumor 1


subject: UNII:6GNT3Y5LMF

object_name: testicular germ cell tumor


subject: UNII:6GNT3Y5LMF

object_name: childhood testicular germ cell tumor


subject: UNII:6GNT3Y5LMF

object_name: small intestine cancer


subject: UNII:6GNT3Y5LMF

object_name: small intestine carcinoma


subject: UNII:6GNT3Y5LMF

object_name: ovarian cancer


subject: UNII:6GNT3Y5LMF

object_name: ovarian neoplasm


subject: UNII:6GNT3Y5LMF

object_name: ovarian carcinoma


subject: UNII:6GNT3Y5LMF

object_name: lung cancer


subject: UNII:6GNT3Y5LMF

object_name: lung neoplasm


subject: UNII:6GNT3Y5LMF

object_name: lung carcinoma


subject: UNII:6GNT3Y5LMF

object_name: Childhood Breast Carcinoma


subject: UNII:6GNT3Y5LMF

object_name: breast carcinoma


subject: UNII:6GNT3Y5LMF

object_name: breast cancer


subject: CHEBI:63598

subject_name: Levofloxacin

object_name: adult lymphoma


subject: CHEBI:63598

object_name: lymphoma


subject: CHEBI:63598

object_name: pediatric lymphoma


subject: CHEBI:63598

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:63598

object_name: extragonadal germ cell tumor


subject: CHEBI:63598

object_name: testicular germ cell tumor 1


subject: CHEBI:63598

object_name: testicular germ cell tumor


subject: CHEBI:63598

object_name: childhood testicular germ cell tumor


subject: CHEBI:63598

object_name: small intestine cancer


subject: CHEBI:63598

object_name: small intestine carcinoma


subject: CHEBI:63598

object_name: ovarian cancer


subject: CHEBI:63598

object_name: ovarian neoplasm


subject: CHEBI:63598

object_name: ovarian carcinoma


subject: CHEBI:63598

object_name: lung cancer


subject: CHEBI:63598

object_name: lung neoplasm


subject: CHEBI:63598

object_name: lung carcinoma


subject: CHEBI:63598

object_name: Childhood Breast Carcinoma


subject: CHEBI:63598

object_name: breast carcinoma


subject: CHEBI:63598

object_name: breast cancer


subject: UNII:04XPW8C0FL

subject_name: Aprotinin


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Locally Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:135565596

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:173077


subject: CHEBI:173077


subject: UNII:7N13IK9LNH


subject: UNII:7N13IK9LNH


subject: DRUGBANK:DB19041

subject_name: Elimusertib


subject: DRUGBANK:DB19041


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin

object_name: type 2 diabetes mellitus


subject: UNII:D7RD81HE4W

object_name: Diabetes


subject: UNII:D7RD81HE4W

object_name: diabetes mellitus


subject: UNII:D7RD81HE4W

object_name: Graft Rejection


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: CHEBI:135931

subject_name: Dexlansoprazole

object_name: Chest pain


subject: UMLS:C0360094

subject_name: iv lidocaine

object_name: chronic pancreatitis


subject: CHEBI:48935

subject_name: roxithromycin

object_name: rheumatoid arthritis


subject: CHEBI:32109

subject_name: (Z)-roxithromycin


subject: CHEBI:27732

subject_name: Caffeine

object_name: Caffeine withdrawal


subject: UMLS:C3896826

subject_name: TPO Mimetic LGD-4665

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:4907

subject_name: Etidronic acid

object_name: pseudoxanthoma elasticum (inherited or acquired)


subject: CHEBI:4907

object_name: elastoma


subject: CHEBI:4907

object_name: autosomal recessive inherited pseudoxanthoma elasticum


subject: CHEBI:49845

subject_name: (R)-quinacrine

object_name: prion disease


subject: CHEBI:8711

subject_name: Quinacrine


subject: CHEBI:233415

object_name: malignant glioma


subject: CHEBI:233415

object_name: glioma susceptibility 1


subject: CHEBI:233415

object_name: adult oligodendroglioma


subject: CHEBI:233415

object_name: oligodendroglioma


subject: CHEBI:233415

object_name: childhood oligodendroglioma


subject: CHEBI:233415

object_name: Childhood Astrocytoma


subject: CHEBI:233415

object_name: astrocytic tumor


subject: CHEBI:233415

object_name: astrocytoma


subject: MESH:C000625742


subject: MESH:C000625742


subject: MESH:C000625742


subject: MESH:C000625742


subject: MESH:C000625742


subject: MESH:C000625742


subject: MESH:C000625742


subject: MESH:C000625742


subject: UMLS:C4287721


subject: UMLS:C4287721


subject: UMLS:C4287721


subject: UMLS:C4287721


subject: UMLS:C4287721


subject: UMLS:C4287721


subject: UMLS:C4287721


subject: UMLS:C4287721


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:I031V2H011

object_name: amyotrophic lateral sclerosis


subject: UNII:I031V2H011

object_name: motor neuron disorder


subject: MESH:C484525

subject_name: ovcon 35

object_name: Uses oral contraception (finding)


subject: MESH:C000712209

object_name: rheumatoid arthritis


subject: MESH:C000712209

object_name: juvenile dermatomyositis


subject: MESH:C000712209

object_name: myositis


subject: MESH:C000712209

object_name: Myositis, CTCAE 5.0


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:41423


subject: CHEBI:41423


subject: MESH:C000709016


subject: MESH:C000709016


subject: MESH:C000709016


subject: MESH:C000709016


subject: UMLS:C1446425

subject_name: Cola antigen

object_name: Plexosarcoma


subject: UMLS:C1623185

subject_name: Cola


subject: UMLS:C5706466

subject_name: Cathepsin-targeted Fluorescent Imaging Probe VGT-309

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C4527304

subject_name: Carbon C 11 Glutamine

object_name: Stage IV Colorectal Cancer AJCC v7


subject: UMLS:C4527304

object_name: Stage IV Colorectal Cancer AJCC v6


subject: UMLS:C4527304

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: UMLS:C4527304

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: UMLS:C4527304

object_name: RAS Wild Type


subject: UMLS:C3896904

subject_name: Fluorine F 18 L-glutamate Derivative BAY94-9392


subject: UMLS:C3896904


subject: UMLS:C3896904


subject: UMLS:C3896904


subject: UMLS:C3896904


subject: CHEBI:9150

subject_name: Simvastatin

object_name: tuberous sclerosis


subject: CHEBI:9150

object_name: situs inversus


subject: CHEBI:9150

object_name: tuberous sclerosis 1


subject: CHEBI:9150

object_name: lymphangioleiomyomatosis


subject: CHEBI:9150

object_name: lung lymphangioleiomyomatosis


subject: PUBCHEM.COMPOUND:5458171

subject_name: MITOXANTRONE HYDROCHLORIDE

object_name: Kaposi Sarcoma


subject: PUBCHEM.COMPOUND:5458171

object_name: HIV infection


subject: CHEBI:50729

subject_name: Mitoxantrone


subject: CHEBI:50729


subject: CHEBI:6456

subject_name: Lidocaine

object_name: parathyroid gland disorder


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:94366

subject_name: itraconazole

object_name: Non-small cell lung cancer recurrent


subject: CHEBI:125354

subject_name: Plerixafor

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:125354

object_name: myeloid sarcoma


subject: UMLS:C1446777

subject_name: Rabbit antigen

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C1446777

object_name: childhood myelodysplastic syndrome


subject: UMLS:C1446777

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C2093603

subject_name: Rabbit


subject: UMLS:C2093603


subject: UMLS:C2093603


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:681569

subject_name: Clofarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UNII:B61N8R7TDH

subject_name: Seliforant

object_name: Atopic rhinitis


subject: UNII:B61N8R7TDH

object_name: Hay fever


subject: UMLS:C5433403

subject_name: Forxiga

object_name: type 1 diabetes mellitus 1


subject: UMLS:C5433403

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:21183636

subject_name: Atosiban

object_name: Premature birth


subject: PUBCHEM.COMPOUND:21183636

object_name: premature birth (history)


subject: UMLS:C0078129


subject: UMLS:C0078129


subject: UMLS:C5552956

subject_name: Direct Oral Anticoagulant

object_name: venous thromboembolism


subject: CHEBI:33569

subject_name: noradrenaline

object_name: hepatorenal syndrome


subject: UMLS:C4726000

object_name: urinary bladder carcinoma


subject: UMLS:C4726000

object_name: urinary bladder cancer


subject: UMLS:C4727716

subject_name: GemRIS


subject: UMLS:C4727716


subject: CHEBI:90844

subject_name: Selexipag

object_name: schistosomiasis


subject: CHEBI:90844

object_name: Pulmonary Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: combined hepatocellular carcinoma and cholangiocarcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: CHEBI:151315

subject_name: Heparin

object_name: Embolism and thrombosis of the radial artery


subject: KEGG.COMPOUND:C00374


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: ST-elevation myocardial infarction


subject: CHEBI:73604

object_name: ST Elevation Myocardial Infarction


subject: UMLS:C5782768

subject_name: BUPivacaine 0.25% injectable solution

object_name: congenital heart disease


subject: PR:000004266

subject_name: AT-rich interactive domain-containing protein 3B

object_name: Mild persistent asthma


subject: CHEBI:5147

subject_name: Formoterol


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:50733

subject_name: nutraceutical

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:35366

subject_name: fatty acid


subject: CHEBI:77383

subject_name: 1,1-bis(phosphonic acid)

object_name: osteogenesis imperfecta


subject: UMLS:C3541401

subject_name: Bisphosphonate drugs affecting bone structure and mineralization


subject: MESH:D004164

subject_name: Diphosphonates


subject: PUBCHEM.COMPOUND:50587

subject_name: THYMOPENTIN

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:50587

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:50587

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:50587

object_name: carcinoma


subject: PUBCHEM.COMPOUND:23083982

subject_name: Elvitegravir

object_name: ANTIRETROVIRAL THERAPY INTOLERANCE


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:63716

subject_name: TENOFOVIR


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:228380

subject_name: ANH


subject: CHEBI:228380

object_name: acute kidney failure


subject: CHEBI:228380

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Paresis


subject: CHEBI:3215

object_name: On examination - paresis (weakness) (finding)


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:60802


subject: CHEBI:17026

subject_name: Progesterone

object_name: habitual spontaneous abortion


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: Upper gastrointestinal hemorrhage


subject: UMLS:C5204823


subject: UMLS:C5204823

object_name: cancer


subject: UMLS:C5204823

object_name: neoplasm


subject: CHEBI:50858

subject_name: corticosteroid

object_name: limb-girdle muscular dystrophy


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: DRUGBANK:DB17958


subject: PR:000014391

object_name: acute coronary syndrome


subject: PR:000017598

subject_name: endoribonuclease ZC3H12A


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1134686

subject_name: Fowlpox-Sargramostim Vaccine

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1134686

object_name: Pancreatic carcinoma stage II


subject: UMLS:C1134686

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UMLS:C1134686

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1134686

object_name: stage IV pancreatic cancer


subject: UMLS:C1134686

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C1134686

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UMLS:C1134686

object_name: Pancreatic carcinoma stage III


subject: UMLS:C1134686

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1134686

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C1134686

object_name: colon adenocarcinoma


subject: UMLS:C1134686

object_name: rectum adenocarcinoma


subject: UMLS:C1134686

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C1134686

object_name: pancreatic adenocarcinoma


subject: UMLS:C1134686

object_name: diffuse gastric adenocarcinoma


subject: UMLS:C1134686

object_name: recurrent gastric cancer


subject: UMLS:C1134686

object_name: Malignant neoplasm of stomach stage III


subject: UMLS:C1134686

object_name: Adenocarcinoma of salivary gland


subject: UMLS:C1134686

object_name: Stage IV Colon Cancer AJCC v8


subject: UMLS:C1134686

object_name: Stage IV Colon Cancer AJCC v6


subject: UMLS:C1134686

object_name: Stage IV Colon Cancer AJCC v7


subject: UMLS:C1134686

object_name: Malignant neoplasm of colon stage IV


subject: UMLS:C1134686

object_name: Gastric Mixed Adenocarcinoma


subject: UMLS:C1134686

object_name: Colon cancer recurrent


subject: UMLS:C1134686

object_name: Stage III Colon Cancer AJCC v7


subject: UMLS:C1134686

object_name: Stage III Colon Cancer AJCC v8


subject: UMLS:C1134686

object_name: Stage III Colon Cancer


subject: UMLS:C1134686

object_name: advanced adult primary liver cancer


subject: UMLS:C1134686

object_name: gastric intestinal type adenocarcinoma


subject: UMLS:C1134686

object_name: gallbladder adenocarcinoma


subject: UMLS:C1134686

object_name: male breast carcinoma


subject: UMLS:C1134686

object_name: ovarian endometrioid adenocarcinoma


subject: UMLS:C1134686

object_name: stage II testicular cancer


subject: UMLS:C1134686

object_name: stage III testicular cancer


subject: UMLS:C1134686

object_name: Testis cancer recurrent


subject: UMLS:C1134686

object_name: Paget's disease and infiltrating duct carcinoma of breast


subject: UMLS:C1134686

object_name: Paget's disease and intraductal carcinoma of breast


subject: UMLS:C1134686

object_name: Stage IV Rectal Cancer AJCC v8


subject: UMLS:C1134686

object_name: Stage IV Rectal Cancer AJCC v7


subject: UMLS:C1134686

object_name: Rectal cancer stage IV


subject: UMLS:C1134686

object_name: Stage IV Rectal Cancer AJCC v6


subject: UMLS:C1134686

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C1134686

object_name: Carcinoma breast stage IV


subject: UMLS:C1134686

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1134686

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C1134686

object_name: Stage III Rectal Cancer AJCC v6


subject: UMLS:C1134686

object_name: Stage III Rectal Cancer AJCC v7


subject: UMLS:C1134686

object_name: Stage III Rectal Cancer AJCC v8


subject: UMLS:C1134686

object_name: Breast cancer recurrent


subject: UMLS:C1134686

object_name: Recurrent Rectal Cancer


subject: UMLS:C1134686

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1134686

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1134686

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C1134686

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C1134686

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1134686

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1134686

object_name: Recurrent Salivary Gland Cancer


subject: UMLS:C1134686

object_name: Salivary gland cancer stage IV


subject: UMLS:C1134686

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1134686

object_name: Salivary gland cancer stage III


subject: UMLS:C1134686

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UMLS:C1134686

object_name: cholangiocarcinoma of the gallbladder


subject: UMLS:C1134686

object_name: Recurrent Cancer of Gallbladder


subject: UMLS:C1134686

object_name: Malignant neoplasm of gallbladder recurrent


subject: UMLS:C1134686

object_name: Recurrent Adult Liver Carcinoma


subject: UMLS:C1134686

object_name: Unresectable Gallbladder Carcinoma


subject: UMLS:C1134686

object_name: medullary thyroid gland carcinoma


subject: UMLS:C1134686

object_name: adult hepatocellular carcinoma


subject: UMLS:C1134686

object_name: liver carcinoma


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: UNII:5TAA004E22

object_name: Pancreatic carcinoma stage II


subject: UNII:5TAA004E22

object_name: Stage II Pancreatic Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: colon adenocarcinoma


subject: UNII:5TAA004E22

object_name: rectum adenocarcinoma


subject: UNII:5TAA004E22

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:5TAA004E22

object_name: pancreatic adenocarcinoma


subject: UNII:5TAA004E22

object_name: diffuse gastric adenocarcinoma


subject: UNII:5TAA004E22

object_name: recurrent gastric cancer


subject: UNII:5TAA004E22

object_name: Malignant neoplasm of stomach stage III


subject: UNII:5TAA004E22

object_name: Adenocarcinoma of salivary gland


subject: UNII:5TAA004E22

object_name: Gastric Mixed Adenocarcinoma


subject: UNII:5TAA004E22

object_name: Stage III Colon Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Stage III Colon Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Stage III Colon Cancer


subject: UNII:5TAA004E22

object_name: advanced adult primary liver cancer


subject: UNII:5TAA004E22

object_name: gastric intestinal type adenocarcinoma


subject: UNII:5TAA004E22

object_name: gallbladder adenocarcinoma


subject: UNII:5TAA004E22

object_name: stage II testicular cancer


subject: UNII:5TAA004E22

object_name: stage III testicular cancer


subject: UNII:5TAA004E22

object_name: Testis cancer recurrent


subject: UNII:5TAA004E22

object_name: Paget's disease and infiltrating duct carcinoma of breast


subject: UNII:5TAA004E22

object_name: Paget's disease and intraductal carcinoma of breast


subject: UNII:5TAA004E22

object_name: Stage III Rectal Cancer AJCC v6


subject: UNII:5TAA004E22

object_name: Stage III Rectal Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Stage III Rectal Cancer AJCC v8


subject: UNII:5TAA004E22

object_name: Recurrent Salivary Gland Cancer


subject: UNII:5TAA004E22

object_name: Salivary gland cancer stage IV


subject: UNII:5TAA004E22

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: Salivary gland cancer stage III


subject: UNII:5TAA004E22

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: UNII:5TAA004E22

object_name: cholangiocarcinoma of the gallbladder


subject: UNII:5TAA004E22

object_name: Recurrent Cancer of Gallbladder


subject: UNII:5TAA004E22

object_name: Malignant neoplasm of gallbladder recurrent


subject: UNII:5TAA004E22

object_name: Recurrent Adult Liver Carcinoma


subject: UNII:5TAA004E22

object_name: Unresectable Gallbladder Carcinoma


subject: UNII:5TAA004E22

object_name: medullary thyroid gland carcinoma


subject: UNII:5TAA004E22

object_name: adult hepatocellular carcinoma


subject: PR:000005931

object_name: Stage II Pancreatic Cancer AJCC v6 and v7


subject: PR:000005931

object_name: Pancreatic carcinoma stage II


subject: PR:000005931

object_name: Stage II Pancreatic Cancer AJCC v8


subject: PR:000005931

object_name: colon adenocarcinoma


subject: PR:000005931

object_name: rectum adenocarcinoma


subject: PR:000005931

object_name: Malignant neoplasm of stomach stage IV


subject: PR:000005931

object_name: pancreatic adenocarcinoma


subject: PR:000005931

object_name: diffuse gastric adenocarcinoma


subject: PR:000005931

object_name: recurrent gastric cancer


subject: PR:000005931

object_name: Malignant neoplasm of stomach stage III


subject: PR:000005931

object_name: Adenocarcinoma of salivary gland


subject: PR:000005931

object_name: Gastric Mixed Adenocarcinoma


subject: PR:000005931

object_name: Stage III Colon Cancer AJCC v7


subject: PR:000005931

object_name: Stage III Colon Cancer AJCC v8


subject: PR:000005931

object_name: Stage III Colon Cancer


subject: PR:000005931

object_name: advanced adult primary liver cancer


subject: PR:000005931

object_name: gastric intestinal type adenocarcinoma


subject: PR:000005931

object_name: gallbladder adenocarcinoma


subject: PR:000005931

object_name: stage II testicular cancer


subject: PR:000005931

object_name: stage III testicular cancer


subject: PR:000005931

object_name: Testis cancer recurrent


subject: PR:000005931

object_name: Paget's disease and infiltrating duct carcinoma of breast


subject: PR:000005931

object_name: Paget's disease and intraductal carcinoma of breast


subject: PR:000005931

object_name: Stage III Rectal Cancer AJCC v6


subject: PR:000005931

object_name: Stage III Rectal Cancer AJCC v7


subject: PR:000005931

object_name: Stage III Rectal Cancer AJCC v8


subject: PR:000005931

object_name: Recurrent Salivary Gland Cancer


subject: PR:000005931

object_name: Salivary gland cancer stage IV


subject: PR:000005931

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: PR:000005931

object_name: Salivary gland cancer stage III


subject: PR:000005931

object_name: Stage III Major Salivary Gland Cancer AJCC v7


subject: PR:000005931

object_name: cholangiocarcinoma of the gallbladder


subject: PR:000005931

object_name: Recurrent Cancer of Gallbladder


subject: PR:000005931

object_name: Malignant neoplasm of gallbladder recurrent


subject: PR:000005931

object_name: Recurrent Adult Liver Carcinoma


subject: PR:000005931

object_name: Unresectable Gallbladder Carcinoma


subject: PR:000005931

object_name: medullary thyroid gland carcinoma


subject: PR:000005931

object_name: adult hepatocellular carcinoma


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: hyperlipidemia


subject: UMLS:C3714501

object_name: hyperlipoproteinemia


subject: UMLS:C3714501

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C3714501

object_name: Serum lipids high (finding)


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: UMLS:C5418082

object_name: ovarian carcinoma


subject: UMLS:C5418082

object_name: malignant epithelial tumor of ovary


subject: UMLS:C5418082

object_name: primary peritoneal carcinoma


subject: UMLS:C5418082

object_name: Primary Peritoneal Cancer


subject: UMLS:C5418082

object_name: fallopian tube carcinoma


subject: UMLS:C5418082

object_name: fallopian tube cancer


subject: PUBCHEM.COMPOUND:146567655

subject_name: Osivelotor

object_name: sickle cell disease


subject: UNII:UK749B4S16

subject_name: OSIVELOTOR


subject: UMLS:C5706367

subject_name: Anti-HJV Monoclonal Antibody DISC-0974

object_name: anemia


subject: UMLS:C5706367

object_name: Anemia, CTCAE


subject: UMLS:C5706367

object_name: myelofibrosis


subject: UMLS:C5706367

object_name: Myelodysplasia


subject: UMLS:C5706367

object_name: anemia; myelofibrosis


subject: UMLS:C5706367


subject: UMLS:C5706367

object_name: Post-polycythemia vera myelofibrosis


subject: DRUGBANK:DB15656

subject_name: ChAdOx1 nCoV-19

object_name: COVID-19 respiratory infection


subject: UMLS:C5432330

subject_name: Covishield


subject: UMLS:C1314412

subject_name: INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED

object_name: lichen planus


subject: UNII:ELK3V90G6C

subject_name: Alefacept


subject: UMLS:C5556786

subject_name: TGF-beta Receptor 1 Inhibitor GFH018

object_name: Non-small cell lung cancer stage III


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: Adhesive Capsulitis


subject: CHEBI:144903

object_name: frozen shoulder


subject: CHEBI:144903

object_name: bursitis


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: CHEBI:6413

subject_name: Letrozole

object_name: tubal pregnancy


subject: UMLS:C5140536

subject_name: Zolgensma

object_name: spinal muscular atrophy


subject: UMLS:C0051530

subject_name: alvogyl

object_name: Pain, Procedural


subject: MESH:C079198

subject_name: S 1 (combination)

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:156526655

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:156526655

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:156526655

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:156526655

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:156526655

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:156526655

object_name: colorectal carcinoma


subject: UMLS:C5785443

subject_name: SOS1 Inhibitor MRTX0902


subject: UMLS:C5785443


subject: UMLS:C5785443


subject: UMLS:C5785443


subject: UMLS:C5785443


subject: UMLS:C5785443


subject: UMLS:C4763658

subject_name: KRAS G12C inhibitor MRTX849


subject: UMLS:C4763658


subject: UMLS:C4763658


subject: UMLS:C4763658


subject: CHEBI:233309

subject_name: Adagrasib


subject: CHEBI:233309


subject: UMLS:C5418121


subject: UNII:IL870Q3Z8I

subject_name: Cobiprostone

object_name: portal hypertension


subject: UNII:IL870Q3Z8I

object_name: Portal Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:3367

object_name: Transformed Non-Hodgkin Lymphoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:231621

subject_name: Tasisulam


subject: UMLS:C1831958


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Drug Interactions


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Chronic gouty arthritis


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: PR:000010755


subject: UNII:R581OT55EA

subject_name: PEG-uricase


subject: UMLS:C3273718

subject_name: Maveropepimut-S

object_name: Recurrent tumor


subject: UMLS:C3273718

object_name: Adult Diffuse Large Cell Lymphoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Plaque, Atherosclerotic


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Carbon Monoxide Poisoning


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:135926

subject_name: Udenafil

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:135926

object_name: chronic obstructive pulmonary disease


subject: CHEBI:135926

object_name: Dyspnea


subject: CHEBI:135926

object_name: Dyspnea, CTCAE


subject: CHEBI:135926

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:40279

subject_name: Allopurinol

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:40279

object_name: metabolic syndrome X


subject: UMLS:C0939333

subject_name: Estradiol Patch


subject: CHEBI:16118

subject_name: Berberine

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:16118

object_name: HIV-1 infection


subject: CHEBI:16118

object_name: lipodystrophy


subject: CHEBI:16118

object_name: Lipoatrophy


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED

object_name: Puerperal endometritis


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: Puerperal sepsis


subject: CHEBI:51254


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Oral health


subject: CHEBI:230386

subject_name: Pimonidazole

object_name: tongue cancer


subject: CHEBI:230386

object_name: tongue carcinoma


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: Sedation


subject: CHEBI:4636

object_name: Sedated


subject: CHEBI:50692

subject_name: Mifepristone

object_name: submucous uterine fibroid


subject: CHEBI:5523

subject_name: Goserelin


subject: UMLS:C0149473

subject_name: Zoladex


subject: UMLS:C4762491

subject_name: Del Nido Cardioplegia

object_name: Cardiac Events


subject: UMLS:C5848169

subject_name: Nadroparin Calcium

object_name: ANTICOAGULATION (finding)


subject: UNII:LIA7Z4002P

subject_name: Nadroparin


subject: CHEBI:132922

object_name: Chronic low back pain


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: Brain Stem Glioblastoma


subject: PUBCHEM.COMPOUND:135423438

object_name: glioma susceptibility 1


subject: UMLS:C1879771

subject_name: BIBF 1120


subject: UMLS:C1879771


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:9943

subject_name: Venlafaxine

object_name: neuralgia


subject: CHEBI:9943

object_name: Neuropathic pain


subject: CHEBI:9943

object_name: chronic pain (diagnosis)


subject: CHEBI:9943

object_name: Chronic pain


subject: CHEBI:9943

object_name: Acute Pain


subject: CHEBI:9943

object_name: knee pain chronic


subject: PUBCHEM.COMPOUND:78122784

subject_name: Tenapanor

object_name: Hyperoxaluria


subject: UMLS:C5237725

subject_name: Pan-KRAS Inhibitor BI 1701963

object_name: Advanced cancer


subject: UMLS:C5237725

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5237725

object_name: Embolism, Tumor


subject: UMLS:C5237725

object_name: Neoplasm Metastasis


subject: UMLS:C5237725

object_name: colon cancer


subject: UMLS:C5237725

object_name: lung cancer


subject: UMLS:C5237725

object_name: cancer


subject: UMLS:C4763658

subject_name: KRAS G12C inhibitor MRTX849


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: arthritis


subject: CHEBI:94518

object_name: Arthritis, CTCAE


subject: UMLS:C4331801

object_name: glioma


subject: UMLS:C4331801

object_name: malignant glioma


subject: UMLS:C0003233

subject_name: Antibiotics, Aminoglycoside

object_name: acute kidney failure


subject: UMLS:C0003233

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:47779

subject_name: aminoglycoside


subject: CHEBI:47779


subject: UMLS:C3536835

subject_name: Aminoglycoside [EPC]


subject: UMLS:C3536835


subject: CHEBI:9241

subject_name: Spironolactone

object_name: myocardial infarction


subject: CHEBI:9241

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:9241

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C4045874

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: Acute Heart Failure Related to COVID-19


subject: PUBCHEM.COMPOUND:24993045

object_name: Acute heart failure


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C4287697


subject: UMLS:C3886615

object_name: photosensitive epilepsy


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Physical trauma


subject: CHEBI:5118

object_name: Injury


subject: CHEBI:5118

object_name: Trauma


subject: CHEBI:190273

subject_name: Orellanine

object_name: renal cell carcinoma


subject: UNII:082U1GSX3D


subject: CHEBI:229722

subject_name: camonsertib

object_name: Childhood Solid Neoplasm


subject: CHEBI:229722

object_name: Adult Solid Neoplasm


subject: CHEBI:229722

object_name: Solid Neoplasm


subject: CHEBI:229722

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:229722

object_name: Embolism, Tumor


subject: CHEBI:229722

object_name: Neoplasm Metastasis


subject: UMLS:C5418075

subject_name: ATR Inhibitor RP-3500


subject: UMLS:C5418075


subject: UMLS:C5418075


subject: UMLS:C5418075


subject: UMLS:C5418075


subject: UMLS:C5418075


subject: CHEBI:63632

subject_name: Topotecan

object_name: Generalised illness


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: CHEBI:83800

subject_name: daclatasvir hydrochloride

object_name: chronic hepatitis C virus infection


subject: CHEBI:76607

subject_name: Macitentan

object_name: Heart failure with normal ejection fraction


subject: UMLS:C0908244

subject_name: NXY 059

object_name: intracerebral hemorrhage


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: heart disorder


subject: UMLS:C0812735

object_name: aneurysm


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:233408

subject_name: Olesoxime

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:233408

object_name: amyotrophic lateral sclerosis


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: Promyelocytic leukemia


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: UNII:S7V92P67HO


subject: CHEBI:15367

subject_name: Tretinoin


subject: PUBCHEM.COMPOUND:86294067

object_name: Diabetic peripheral neuropathic pain


subject: CHEMBL.COMPOUND:CHEMBL2109625

object_name: West Nile viral infection


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: PR:000005503

object_name: biliary tract neoplasm


subject: PR:000005503


subject: PR:000005503


subject: PR:000005503

object_name: gallbladder cancer


subject: PR:000005503


subject: PR:000005503


subject: PR:000005503


subject: PR:000005503

object_name: gallbladder carcinoma


subject: PR:000005503

object_name: cholangiocarcinoma


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Miscarriage


subject: CHEBI:135207

object_name: spontaneous abortion


subject: CHEBI:135207

object_name: birth (history)


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: CHEBI:15365


subject: CHEBI:84883

subject_name: Icosapent ethyl

object_name: colon cancer liver metastasis


subject: UMLS:C4763658

subject_name: KRAS G12C inhibitor MRTX849

object_name: Metastatic non-small cell lung cancer


subject: UNII:2285XW22DR

subject_name: cixutumumab

object_name: Metastatic osteosarcoma


subject: UMLS:C2699335


subject: CHEBI:79699

subject_name: Temsirolimus


subject: UMLS:C3886640

object_name: glioblastoma


subject: UMLS:C3886640

object_name: Childhood Glioblastoma


subject: UMLS:C3886640

object_name: adult glioblastoma


subject: PUBCHEM.COMPOUND:77256380

subject_name: Glasdegib


subject: PUBCHEM.COMPOUND:77256380


subject: PUBCHEM.COMPOUND:77256380


subject: CHEBI:35679

subject_name: antilipemic drug

object_name: chronic hepatitis B virus infection


subject: CHEBI:35679

object_name: inherited lipid metabolism disorder


subject: CHEBI:53795

subject_name: (R)-amlodipine


subject: CHEBI:53795


subject: CHEBI:63660

object_name: Prediabetes


subject: CHEBI:63618

subject_name: Pravastatin


subject: UNII:4V59G5UW9X

subject_name: Argan oil

object_name: age


subject: UNII:TC549UFL8P


subject: UMLS:C1831848


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Childhood Synovial Sarcoma


subject: CHEBI:231679

object_name: Adult Synovial Sarcoma


subject: CHEBI:231679

object_name: synovial sarcoma


subject: UMLS:C4723695

subject_name: penpulimab

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C4723695

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C4723695

object_name: sarcoma


subject: UMLS:C4723695

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C4723695

object_name: soft tissue sarcoma


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: type 1 diabetes mellitus 1


subject: CHEBI:46195

object_name: type 1 diabetes mellitus


subject: CHEBI:51098

subject_name: Motesanib

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL2107856

subject_name: IMETELSTAT


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: Advanced breast cancer


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Friedreich ataxia